ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in October 2020. Updated November 2.
A roundup of FDA’s actions in October 2020.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in October 2020. Updated November 2.
A roundup of FDA’s actions in October 2020.